These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11078423)

  • 1. Mixed endothelin ET(A) and ET(B) antagonist bosentan inhibits oleic acid-induced lung plasma extravasation in mouse.
    Guimarães CL; Da-Silva S; Couture R; Rae GA
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S371-3. PubMed ID: 11078423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin ET(B) receptor-mediated mechanisms involved in oleic acid-induced acute lung injury in mice.
    Guimarães CL; Trentin PG; Rae GA
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():340S-344S. PubMed ID: 12193118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin receptor blockade in canine oleic acid-induced lung injury.
    Hubloue I; Biarent D; Abdel Kafi S; Bejjani G; Mélot C; Naeije R; Leeman M
    Intensive Care Med; 2003 Jun; 29(6):1003-1006. PubMed ID: 12734647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of endothelins and sarafotoxin 6c in the rat isolated perfused lung.
    Lal H; Woodward B; Williams KI
    Br J Pharmacol; 1995 Jun; 115(4):653-9. PubMed ID: 7582486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of endothelin antagonists, including the novel ET(A) receptor antagonist LBL 031, on endothelin-1 and lipopolysaccharide-induced microvascular leakage in rat airways.
    Hele DJ; Birrell MA; Webber SE; Foster ML; Belvisi MG
    Br J Pharmacol; 2000 Nov; 131(6):1129-34. PubMed ID: 11082120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Ro 47-0203 and PD155080 on the plasma kinetics, receptor binding and vascular effects of endothelin in the pig.
    Hemsén A; Modin A; Wanecek M; Malmström RE; Weitzberg E
    Eur J Pharmacol; 1996 Dec; 318(2-3):369-76. PubMed ID: 9016927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat.
    Filep JG; Földes-Filep E; Rousseau A; Sirois P; Fournier A
    Br J Pharmacol; 1993 Nov; 110(3):1213-21. PubMed ID: 8298811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for endogenous endothelin in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats.
    Filep JG
    Br J Pharmacol; 2000 Mar; 129(5):975-83. PubMed ID: 10696098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the ETA/ETB receptor antagonist, bosentan on endothelin-1-induced myocardial ischaemia and oedema in the rat.
    Filep JG; Fournier A; Földes-Filep E
    Br J Pharmacol; 1995 Sep; 116(2):1745-50. PubMed ID: 8528554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
    Kaddoura S; Firth JD; Boheler KR; Sugden PH; Poole-Wilson PA
    Circulation; 1996 Jun; 93(11):2068-79. PubMed ID: 8640984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
    Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
    Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin ET
    Vercauteren M; Trensz F; Pasquali A; Cattaneo C; Strasser DS; Hess P; Iglarz M; Clozel M
    J Pharmacol Exp Ther; 2017 May; 361(2):322-333. PubMed ID: 28223322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive effect of phosphoenolpyruvate on hypoxemia induced by oleic acid in Guinea pigs.
    Golbidi S; Moriuchi H; Yang C; Irikura M; Irie T; Hamasaki N
    Biol Pharm Bull; 2003 Mar; 26(3):336-40. PubMed ID: 12612443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro.
    Magga J; Vuolteenaho O; Marttila M; Ruskoaho H
    Circulation; 1997 Nov; 96(9):3053-62. PubMed ID: 9386175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the endothelin receptor antagonist Bosentan on ischaemia/reperfusion injury in rat skeletal muscle.
    Herbert KJ; Hickey MJ; Lepore DA; Knight KR; Morrison WA; Stewart AG
    Eur J Pharmacol; 2001 Jul; 424(1):59-67. PubMed ID: 11470261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.
    Richard V; Kaeffer N; Hogie M; Tron C; Blanc T; Thuillez C
    Br J Pharmacol; 1994 Nov; 113(3):869-76. PubMed ID: 7858879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine renal endothelin system in rats with liver cirrhosis.
    Hocher B; Zart R; Diekmann F; Rohmeiss P; Distler A; Neumayer HH; Bauer C; Gross P
    Br J Pharmacol; 1996 May; 118(2):220-7. PubMed ID: 8735618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous endothelin modulates blood pressure, plasma volume, and albumin escape after systemic nitric oxide blockade.
    Filep JG
    Hypertension; 1997 Jul; 30(1 Pt 1):22-8. PubMed ID: 9231816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bosentan the mixed endothelin-A- and -B-receptor antagonist suppresses intrapericardial endothelin-1-induced ventricular arrhythmias.
    Horkay F; Gellér L; Kiss O; Szabó T; Vagó H; Kékesi V; Juhász-Nagy A; Merkely B
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S320-2. PubMed ID: 11078409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.